These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 11103440

  • 1. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B, Hess T, Jost R, Ballmer PE, Imoberdorf R.
    Schweiz Med Wochenschr; 2000 Nov 04; 130(44):1681-4. PubMed ID: 11103440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The approach to recurrent infections with Clostridium difficile].
    Paz Z, Altman A.
    Harefuah; 2008 Nov 04; 147(11):864-5, 942. PubMed ID: 19264004
    [Abstract] [Full Text] [Related]

  • 5. Treatment of recurrent Clostridium difficile-associated disease.
    Surawicz CM.
    Nat Clin Pract Gastroenterol Hepatol; 2004 Nov 04; 1(1):32-8. PubMed ID: 16265042
    [Abstract] [Full Text] [Related]

  • 6. Saccharomyces boulardii for the treatment of Clostridium difficile-associated colitis.
    Eddy JT, Stamatakis MK, Makela EH.
    Ann Pharmacother; 1997 Nov 04; 31(7-8):919-21. PubMed ID: 9220059
    [Abstract] [Full Text] [Related]

  • 7. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S.
    J Infect; 2009 Jun 04; 58(6):403-10. PubMed ID: 19394704
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Relapsing infections with Clostridium difficile].
    Visser WE, Dingemans-Dumas AM, Bac DJ.
    Ned Tijdschr Geneeskd; 2005 Oct 22; 149(43):2381-5. PubMed ID: 16277125
    [Abstract] [Full Text] [Related]

  • 10. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    Schweitzer MA, Sweiss I, Silver DL, Stellato TA.
    Am Surg; 1996 Jul 22; 62(7):603-7; discussion 607-8. PubMed ID: 8651560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
    McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ.
    Dis Colon Rectum; 2006 May 22; 49(5):640-5. PubMed ID: 16525744
    [Abstract] [Full Text] [Related]

  • 13. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV, Elmer GW, Surawicz CM.
    Am J Gastroenterol; 2002 Jul 22; 97(7):1769-75. PubMed ID: 12135033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment strategies for C. difficile associated diarrhea.
    Stepan C, Surawicz CM.
    Acta Gastroenterol Latinoam; 2007 Sep 22; 37(3):183-91. PubMed ID: 17955730
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of infections associated with Clostridium difficile].
    Szczesny A, Martirosian G.
    Wiad Lek; 2003 Sep 22; 56(5-6):278-82. PubMed ID: 14526488
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ.
    Clin Infect Dis; 2008 Jul 01; 47(1):56-62. PubMed ID: 18491964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.